Journal of Neurology

, Volume 259, Issue 5, pp 985–988 | Cite as

Detection of anti-glutamate receptor ε2 and anti-N-methyl-d-aspartate receptor antibodies in a patient with sporadic Creutzfeldt–Jakob disease

  • Koji Fujita
  • Tatsuhiko Yuasa
  • Yukitoshi Takahashi
  • Keiko Tanaka
  • Shuji Hashiguchi
  • Katsuhito Adachi
  • Yuishin Izumi
  • Ryuji Kaji
Letter to the Editors

References

  1. 1.
    Stoeck K, Bodemer M, Ciesielczyk B, Meissner B, Bartl M, Heinemann U, Zerr I (2005) Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol 62:1591–1594PubMedCrossRefGoogle Scholar
  2. 2.
    Stoeck K, Bodemer M, Zerr I (2006) Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol 172:175–181PubMedCrossRefGoogle Scholar
  3. 3.
    World Health Organization (1998) Human transmissible spongiform encephalopathies. WHO Week Epidemiol Rec 73:361–372Google Scholar
  4. 4.
    Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, Yamada M, Mizusawa H, Kitamoto T, Klug G, McGlade A, Collins SJ, Nishida N (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175–178PubMedCrossRefGoogle Scholar
  5. 5.
    Takahashi Y, Mori H, Mishina M, Watanabe M, Fujiwara T, Shimomura J, Aiba H, Miyajima T, Saito Y, Nezu A, Nishida H, Imai K, Sakaguchi N, Kondo N (2003) Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 61:891–896PubMedCrossRefGoogle Scholar
  6. 6.
    Tachibana N, Shirakawa T, Ishii K, Takahashi Y, Tanaka K, Arima K, Yoshida T, Ikeda S (2010) Expression of various glutamate receptors including N-methyl-d-aspartate receptor (NMDAR) in an ovarian teratoma removed from a young woman with anti-NMDAR encephalitis. Intern Med 49:2167–2173PubMedCrossRefGoogle Scholar
  7. 7.
    Hamaguchi T, Kitamoto T, Sato T, Mizusawa H, Nakamura Y, Noguchi M, Furukawa Y, Ishida C, Kuji I, Mitani K, Murayama S, Kohriyama T, Katayama S, Yamashita M, Yamamoto T, Udaka F, Kawakami A, Ihara Y, Nishinaka T, Kuroda S, Suzuki N, Shiga Y, Arai H, Maruyama M, Yamada M (2005) Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 64:643–648PubMedCrossRefGoogle Scholar
  8. 8.
    Kimura A, Sakurai T, Suzuki Y, Hayashi Y, Hozumi I, Watanabe O, Arimura K, Takahashi Y, Inuzuka T (2007) Autoantibodies against glutamate receptor ε2-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis. Eur Neurol 58:152–158PubMedCrossRefGoogle Scholar
  9. 9.
    Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36PubMedCrossRefGoogle Scholar
  10. 10.
    Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098PubMedCrossRefGoogle Scholar
  11. 11.
    Niehusmann P, Dalmau J, Rudlowski C, Vincent A, Elger CE, Rossi JE, Bien CG (2009) Diagnostic value of N-methyl-d-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 66:458–464PubMedCrossRefGoogle Scholar
  12. 12.
    Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866–5875PubMedCrossRefGoogle Scholar
  13. 13.
    Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL (2008) Rapidly progressive dementia. Ann Neurol 64:97–108PubMedCrossRefGoogle Scholar
  14. 14.
    Geschwind MD, Tan KM, Lennon VA, Barajas RF Jr, Haman A, Klein CJ, Josephson SA, Pittock SJ (2008) Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 65:1341–1346PubMedCrossRefGoogle Scholar
  15. 15.
    Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, Johnson DY, Miller BL, Geschwind MD (2011) Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711–1719PubMedCrossRefGoogle Scholar
  16. 16.
    Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70:504–511PubMedCrossRefGoogle Scholar
  17. 17.
    Ferrer I, Puig B (2003) GluR2/3, NMDAε1 and GABAA receptors in Creutzfeldt-Jakob disease. Acta Neuropathol 106:311–318PubMedCrossRefGoogle Scholar
  18. 18.
    Sotelo J, Gibbs CJ Jr, Gajdusek DC (1980) Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt-Jakob disease. Science 210:190–193PubMedCrossRefGoogle Scholar
  19. 19.
    Toh BH, Gibbs CJ Jr, Gajdusek DC, Goudsmit J, Dahl D (1985) The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases. Proc Natl Acad Sci USA 82:3485–3489PubMedCrossRefGoogle Scholar
  20. 20.
    Wilson C, Hughes L, Rashid T, Cunningham P, Bansal S, Ebringer A, Ettelaie C (2004) Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy. Vet Immunol Immunopathol 98:1–7PubMedCrossRefGoogle Scholar
  21. 21.
    Nomura S, Miyasho T, Maeda N, Doh-ura K, Yokota H (2009) Autoantibody to glial fibrillary acidic protein in the sera of cattle with bovine spongiform encephalopathy. Proteomics 9:4029–4035PubMedCrossRefGoogle Scholar
  22. 22.
    Hu W, Rosenberg RN, Stüve O (2007) Prion proteins: a biological role beyond prion diseases. Acta Neurol Scand 116:75–82PubMedCrossRefGoogle Scholar
  23. 23.
    Tsutsui S, Hahn JN, Johnson TA, Ali Z, Jirik FR (2008) Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis. Am J Pathol 173:1029–1041PubMedCrossRefGoogle Scholar
  24. 24.
    Hu W, Nessler S, Hemmer B, Eagar TN, Kane LP, Leliveld SR, Müller-Schiffmann A, Gocke AR, Lovett-Racke A, Ben LH, Hussain RZ, Breil A, Elliott JL, Puttaparthi K, Cravens PD, Singh MP, Petsch B, Stitz L, Racke MK, Korth C, Stüve O (2010) Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling. Brain 133:375–388PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Koji Fujita
    • 1
  • Tatsuhiko Yuasa
    • 2
  • Yukitoshi Takahashi
    • 3
  • Keiko Tanaka
    • 4
  • Shuji Hashiguchi
    • 5
  • Katsuhito Adachi
    • 5
  • Yuishin Izumi
    • 1
  • Ryuji Kaji
    • 1
  1. 1.Department of Clinical NeuroscienceThe University of Tokushima Graduate SchoolTokushimaJapan
  2. 2.Department of Neurology, Kamagaya-Chiba Medical Center for Intractable Neurological DiseaseKamagaya General HospitalKamagayaJapan
  3. 3.National Epilepsy CenterShizuoka Institute of Epilepsy and Neurological DisordersShizuokaJapan
  4. 4.Department of NeurologyKanazawa Medical UniversityKahokugunJapan
  5. 5.Department of Neurology, Tokushima National HospitalNational Hospital OrganizationYoshinogawaJapan

Personalised recommendations